CDC-FRA-PS17-1707 A.pdf

Image Description: Centers for Disease Control

Centers for Disease Control

National Center for HIV-AIDS, Viral Hepatitis, STD, and TB Prevention

Community Approaches to Reducing Sexually Transmitted Diseases (CARS)

CDC-RFA-PS17-1707

Application Due Date: 05/30/2017

Community Approaches to Reducing Sexually Transmitted Diseases (CARS)

CDC-RFA-PS17-1707

TABLE OF CONTENTS

Part I. Overview Information Federal Agency NameA.

Funding Opportunity TitleB.

Announcement TypeC.

Agency Funding Opportunity NumberD.

Catalog of Federal Domestic Assistance (CFDA) NumberE.

Dates F.

Executive Summary G.

Part II. Full Text Funding Opportunity Description A.

Award Information B.

Eligibility Information C.

Application and Submission Information D.

Review and Selection Process E.

Award Administration Information F.

Agency Contacts G.

Other Information H.

Glossary I.

Part I. Overview Information Applicants must go to the synopsis page of this announcement at www.grants.gov and click on the "Send Me Change Notifications Emails" link to ensure they receive notifications of any changes to CDC-RFA-PS17-1707. Applicants also must provide an e-mail address to www.grants.gov to receive notifications of changes.

A. Federal Agency Name:

Centers for Disease Control and Prevention (CDC) / Agency for Toxic Substances and Disease Registry

(ATSDR)

B. Funding Opportunity Title:

Community Approaches to Reducing Sexually Transmitted Diseases (CARS) C. Announcement Type: New - Type 1 This announcement is only for non-research activities supported by CDC. If research is proposed, the application will not be considered. For this purpose, research is defined at https://www.gpo.gov/fdsys/pkg /CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf. Guidance on how CDC interprets the definition of research in the context of public health can be found at http://www.cdc.gov/od/science/integrity /docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf.

D. Agency Funding Opportunity Number:

CDC-RFA-PS17-1707

E. Catalog of Federal Domestic Assistance (CFDA) Number:

93.978 F. Dates:

1. Due Date for Letter of Intent (LOI): 04/28/2017

2. Due Date for Applications: 05/30/2017, 11:59 p.m. U.S. Eastern Standard Time, at www.grants.gov.

3. Date for Informational Conference Call:

Informational conference call for potential applicants Thursday, April 20, 2017 1:00-2:30pm EST

Join Skype Meeting

Trouble Joining? Try Skype Web App

Join by phone

(404) 553-8912 (Atlanta Dial-in Conference Region) English (United States)

(855) 348-8390 (Atlanta Dial-in Conference Region) English (United States)

Find a local number

Conference ID: 9285150

Forgot your dial-in PIN? |Help

G. Executive Summary:

https://www.grants.gov https://www.grants.gov https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf https://www.grants.gov https://webconf.cdc.gov/nhh9/4M92RZHC https://webconf.cdc.gov/nhh9/4M92RZHC?sl=1 tel:(404)%20553-8912 tel:(855)%20348-8390 https://webaudio.cdc.gov https://webaudio.cdc.gov https://o15.officeredir.microsoft.com/r/rlidLync15?clid=1033&p1=5&p2=2009

1. Summary Paragraph:

The Centers for Disease Control and Prevention (CDC) announces the availability of Fiscal Year (FY) 2017 funds for a cooperative agreement with organizations with demonstrated experience and capacity of implementing community engagement methods (e.g. community-based participatory research) and multi-sector partnerships to promote personal health, advance community wellness, influence personal health behavior and practices, and reduce STD disparities. The new FOA provides support in five focus areas.

These focus areas are: (1) implementation of community engagement methods (e.g. community-based participatory research) to achieve health equity; (2) identification and implementation of systems and environmental change strategies that (a) promote personal health and support healthy behaviors and

(b) facilitate community-clinical linkages to build support for interventions to prevent and reduce STD disparities; (3) enhancement and sustainability of partnerships; (4) support for communication strategies to promote STD program successes and leverage additional resources for STD control and prevention; and (5) evaluation of the efficacy of this approach and intervention implementation.

a. Eligible Applicants: Open Competition

b. FOA Type: Cooperative Agreement

c. Approximate Number of Awards: 4

d. Total Project Period Funding: $3,750,000

e. Average One Year Award Amount: $312,500

f. Total Project Period Length: 3

g. Estimated Award Date: 08/28/2017

h. Cost Sharing and / or Matching Requirements:

N

Part II. Full Text A. Funding Opportunity Description

Part II. Full Text

1. Background

a. Overview

Sexually Transmitted Diseases (STDs) remain one of the most critical public health challenges facing the United States (U.S.), with approximately 20 million new STD infections occurring every year. Nearly half of these new infection occurs in young people ages 15-24. The long-term health and well-being of these individuals is significantly affected by this alarming epidemic. (CDC 2015).

In 2015, a total of 1,526,658 cases of Chlamydia trachomatis infection were reported to the CDC. This case count corresponds to a rate of 478.8 cases per 100,000 population, an increase of 5.9% compared with the rate in 2014. During 2014–2015, the rate of reported chlamydia cases among women increased 3.8% and the rate among men increased 10.5%. Following three years of decreases in rates during 2011–2014, the rate among women aged 15–19 years increased 1.5% during 2014–2015. Rates of reported chlamydia varied among different racial and ethnic minority populations. In 2015, the rate of chlamydia among Blacks was 5.9 times the rate among Whites, and the rate among American Indians/Alaska Natives was

3.8 times the rate among Whites.

In 2015, 395,216 gonorrhea cases were reported for a rate of 123.9 cases per 100,000 population, an increase of 12.8% from 2014. During 2014–2015 the rate of reported gonorrhea increased 18.3% among men and 6.8% among women. Gonorrhea rates among both men and women increased in every region of the United States, with largest increases in the West and the South. The rate of reported gonorrhea cases remained highest among Blacks (424.9 cases per 100,000 population) and among American Indians/Alaska Natives (192.8 cases per 100,000 population). While rates of gonorrhea declined 4.0% among Blacks during 2011–2015, rates increased among all other racial and ethnic groups, including a 71.3% increase among American Indians/Alaska Natives.

During 2014–2015, the primary and secondary (P&S) syphilis rate increased both among men (18.1%) and women (27.3%) and rates increased among both sexes in every region of the country. The rise in the P&S syphilis rate was primarily attributable to increased cases among men and, specifically, among MSM. Reported cases of P&S syphilis continued to be characterized by a high rate of HIV co-infection, particularly among MSM.

The 2015 CDC STD surveillance data show, there are higher rates of reported STDs among some minority populations when compared to rates among whites. Health disparities in HIV, Viral Hepatitis, STDs, and TB are inextricably linked to a complex blend of social determinants that influence which populations are most severely affected by these diseases. Health equity is a desirable goal that entails special efforts to improve the health of those who have experienced social or economic disadvantage. Collaborating with disproportionately affected communities to design, deliver, and assess the impact of public health interventions via influencing relevant social determinants of health in conjunction with routine public health control measures to reduce STD rates is essential for an effective response to the persistent epidemics. Conversely, failing to collaborate with affected communities prior to design and implementation of interventions is counter to the practice of true public health ethics.

Centers for Disease Control and Prevention (CDC), 2015 Sexually Transmitted Diseases Surveillance Report https://www.cdc.gov/std/stats15/default.htm

b. Statutory Authorities This program is authorized under Section 301(a) of the Public Health Service Act (42 U.S.C. Section 241(a)) and 318 (a)(b)(c) of the Public Health Service Act [42 U.S.C. Section 247c (a)(b) and (c)] as amended. Regulations governing the implementation of this legislation are covered under 42 CFR Part 51b, Subpart A.

c. Healthy People 2020 https://www.cdc.gov/std/stats15/default.htm

Due to the substantial STD burden, the U.S. Department of Health and Human Services has identified 10 specific Healthy People objectives for 2020 (http://www.healthypeople.gov/2020/topicsobjectives2020 /objectiveslist.aspx?topicId=37 ). Some of the objectives include:

Reduce the proportion of adolescents and young adults with Chlamydia trachomatis infections.

Reduce Chlamydia rates among females aged 15-44 years.

Reduce gonorrhea rates.

Reduce sustained domestic transmission of primary and secondary syphilis, congenital syphilis.

Reduce the proportion of young adults with genital herpes infection due to herpes simplex type 2.

d. Other National Public Health Priorities and Strategies This FOA supports the NCHHSTP Strategic Plan (https://www.cdc.gov/nchhstp/strategicpriorities/) goals to:

Decrease incidence of infection Decrease morbidity and mortality Decrease health disparities

Through the following NCHHSTP strategies:

Increasing knowledge and adoption of healthy behaviors Prevention through healthcare

This FOA also supports the National Prevention Strategy.https://www.surgeongeneral.gov/priorities/preve ntion/strategy/index.html

e. Relevant Work This FOA builds upon previous and current STD prevention programs including:

CDC-RFA-PS11-1114: http://www.grants.gov/web/grants/view-opportunity.html?oppId=72774

CDC-RFA-PS14-1406: http://www.grants.gov/web/grants/view-opportunity.html?oppId=251204

The Community Approaches to Reducing Sexually Transmitted Diseases (CARS) cooperative agreement was established in 2011 to support planning, implementation, and evaluation of innovative projects to reduce STD disparities, promote personal health, and advance community wellness using community engagement methods. In 2011, four awardees with the capacity to implement projects and activities were funded to carry out this work. In 2014, four new awardees were funded to continue these efforts.

2. CDC Project Description

a. Approach

Bold indicates project period outcome.

Logic Model: Community Approaches to Reducing STD Disparities [bold are outcomes expected during the project period]

Strategies Short Term Outcomes

(Year 1)

Mid-Term Outcomes

(Year 2-3)

Long Term Outcomes

(Year 4- beyond) http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=37 http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=37 https://www.cdc.gov/nchhstp/strategicpriorities/ https://www.surgeongeneral.gov/priorities/prevention/strategy/index.html https://www.surgeongeneral.gov/priorities/prevention/strategy/index.html http://www.grants.gov/web/grants/view-opportunity.html?oppId=72774 http://www.grants.gov/web/grants/view-opportunity.html?oppId=251204

Community Engagement

-Establish a Community Advisory Board (CAB) reflecting at-risk groups

Identification and Implementation of system environmental strategies

- Conduct Community Needs Assessment

- Train CAB and engage CAB in Social Determinants of Health impact/prioritization based on Needs Assessment

- CAB designs STD intervention to address SDH needs

Multi-sectorial partnerships

- Partnership engagement

- Resource leveraging

- Detailed MOUs established

Evaluation/CQI

- Evaluate community engagement, partnerships, and interventions

Increase CAB members who actively participate in and are satisfied with the CAB

Increase prioritization of community social determinants of health by the CAB

Increase clinical resources identified to address needs

Increase number of effective CAB-designed STD interventions for target groups

Increase number of new stable partnerships to address community needs

Increased awareness of STD disparities (e.g., high rates of reported chlamydia, gonorrhea cases among African Americans and Latinos) among target groups most impacted (e.g., adolescents, YMSM, and

MSM)

Increased awareness of personal health issues (e.g., lack of STD prevention and treatment services) affecting target groups and community resources that address needs

Increased linkages with and access to target groups

Increase existing clinical resources for target groups identified by the CAB

Increase number and sustainability of CAB-designed STD interventions using partner resources and influence

Increased access to/use of community health and resources, STD screening and support services by target groups most impacted by STD disparities (e.g., adolescents, YMSM, and MSM)

Increased access to/use of educational and economic opportunities identified in needs assessment by target groups most impacted by STD disparities

Decrease in risky sexual behavior

Decrease in STD disparities

Increase in quality STD prevention services (e.g., health care providers, services more readily accessible)

Decrease in exposure to social issues related to STD transmission

i. Purpose The purpose of this program is to implement community engagement methods to achieve health equity, identify and implement systems and environmental change strategies that promote personal health and support healthy behaviors, facilitate community-clinical linkages to build support for interventions to prevent and reduce STD disparities, enhance and sustain partnerships, support communication strategies that promote STD program successes and leverage additional resources for STD, HIV, viral hepatitis control and prevention, and evaluate the efficacy of this intervention approach.

ii. Outcomes

Awardees are expected to demonstrate measurable progress in:

Short-term

Community Engagement:

Community members actively participate in and are satisfied with the CAB;

Identification and Implementation of system environmental strategies:

Prioritization of community social determinants of health by the CAB Clinical resources are identified to address community needs CAB-designes effective STD interventions for target groups There is an increased awareness of STD disparities (e.g., high rates of reported chlamydia, gonorrhea cases among African Americans and Latinos) among target groups most impacted (e.g., adolescents, YMSM, and MSM), and Awareness of personal health issues (e.g., lack of STD prevention and treatment services) affecting target groups, and community resources that address these needs

Multi-sectorial Partnerships:

There is an increase in the number of new stable partnerships to address community needs

Mid-term

Increase in linkages with, and access to these resources by target groups most affected Increase in existing clinical resources for target groups identified by the CAB Increase in the number and sustainability of CAB-designed STD interventions, using partner resources and influence

iii. Strategies and Activities

Awardees are expected to conduct the activities described below in each of the following Program Strategy areas.

Community Engagement:

Conduct effective community engagement activities (e.g. existing community advisory boards, coalitions, advocates, etc.);

Within the first 3 months, engage the Community Advisory Board (CAB) where at least 85% of members reflect the targeted community most impacted by STD disparities and report using CAB representation table using CDC template;

Ensure the CAB infrastructure is equitable for ALL members and suitable for conducting the business of the board in an efficient manner;

Utilize evaluation, meeting facilitation and continuous quality improvement techniques to ensure active CAB meeting participation, member satisfaction and commitment, sense of ownership and decision-making power.

Identification and implementation of system and environmental strategies:

Within the first 6 months, document and analyze via a community needs assessment, the extent of disparities and the effects of social determinants of health (SDH) on the local community;

Within the first 12 months, engage the CAB in the identification of community priorities for SHD and STD,HIV, and viral hepatitis prevention strategies;

Within the first 12 months, use CAB feedback and community needs assessment data to design a program plan to reduce disparities that addresses social determinants of health;

Within the first 12 months, ensure the incorporation of public health ethics in program plan. Outline specific strategies planned to ensure public health ethics compliance.

Implement CAB designed interventions using partner resources and influence.

Conduct community outreach events and programs for the target group most impacted by STD disparities.

Multisectorial Partnerships:

Partner with other health, non-health, and social service providers (e.g. community health centers, faith-based organizations, mental health agencies, middle and secondary schools, community college networks, professional associations, local health departments, correctional facilities, local businesses) to provide STD, HIV, and viral hepatitis prevention information and referrals, behavioral risk counseling, individual-level interventions and community-designed interventions as identified in the program plan. Within the first 12 months, execute Memorandum of Understanding (MOU) for at least 75% of partners. MOUs must detail specific contributions and supporting activities for partnering programs and/or organizations.

Communication:

Develop and implement effective communication strategies to increase awareness of STD disparities, health issues and community resources among the target population most impacted by STD disparities.

Utilize communication strategies to promote STD program success and leverage additional resources for STD, HIV, and viral hepatitis prevention.

Evaluation:

Within first 3 months, develop a logic model describing program inputs, activities, service outputs, immediate outcomes and long term outcomes.

Within the first 6 months, develop SMART objectives that relate to overall goal of the project. At least one objective must outline how the awardee plans to expand or build upon existing community advisory board.

Within the first 6 months, develop an evaluation plan matrix with evaluation questions, indicators related to the SMART objectives, proposed data collection methods, and timeline. Initial plan should include intentions for the three-year funding period.

Awardees shall report on process and outcome evaluation measures annually. Measures should be directly related to the logic model (service outputs and outcomes) and outcomes listed in this announcement. Measures should be stratified by funding year and include indicators for each funding year.

1. Collaborations

a. With other CDC programs and CDC-funded organizations:

Awardees are expected to collaborate with CDC, NCHHSTP, Division of Sexually Transmitted Disease Prevention (DSTDP), Office of Health Equity (OHE), and Health Services Research and Evaluation Branch (HSREB) to improve program guidance, and evaluation (as requested).

b. With organizations not funded by CDC:

Awardees are expected to build and/or continue strategic partnerships and collaborations with other health, non-health sector, and social service providers (e.g., community health centers, faith-based organizations, mental health agencies, schools, community college networks, professional associations, local health departments, correctional facilities), and others that have a role in achieving the FOA outcomes and proposed activities.

2. Target Populations Applicants should use epidemiologic and social determinants data, e.g., state and local health department surveillance data, to identify communities disproportionately affected by STDs, including HIV and viral hepatitis, within their jurisdictions and should ensure that program activities appropriately cover these populations.

Populations of interest to this announcement include:

Young men-who-have-sex-with-men (YMSM) Men-who-have-sex-with-men (MSM) and other vulnerable populations seen in HIV care and other selected facilities Young transgender persons of color (YTG of color) Adolescents and young adults diagnosed and reported with an STD of interest

a. Health Disparities This FOA is intended to be inclusive of all vulnerable populations including people with disabilities, non-English speaking populations, LGBT populations, people with limited health literacy, and racial/ethnic minorities.

All applicants must design their program so that it is accessible and available to YMSM of color and YTG persons of color. Disparities by race, ethnicity, gender identity, sexual orientation, geography, socioeconomic status, disability status, primary language, health literacy, and other relevant dimensions (e.g., tribal communities) should be considered when developing the proposed program and identifying the target population(s). Organizations that are funded under this FOA will be required to provide services to the primary target population(s) specified in their applications. However, no persons will be turned away from services, regardless of their race, ethnicity, or other demographic characteristics. In addition, the target population described in the work plan and narrative must match the target population identified in the Proposed Target Population Worksheet.

iv. Funding Strategy

b. Evaluation and Performance Measurement

i. CDC Evaluation and Performance Measurement Strategy The CDC evaluation team will:

Conduct a comprehensive evaluation, based on the CARS logic model. Data collection methods will include evaluation assessments, observations, document reviews and key informant interviews.

Collect data on the common evaluation measures listed under measurable outcomes section of the executive summary. This data will be included in the annual evaluation reports.

Measures and Indicators of interest include:

Community Engagement:

Process: Number of members from priority population attending Community Advisory Board (CAB) meetings; level of satisfaction of Community Advisory Board members; number of interventions/strategies that address social determinants of health impacting health equity within affected communities STD disparities identified by CAB; perceived power of CAB members;

perceived ownership of membership structure; perceived sustainability of community engagement methods; improved skill in advocacy among CAB members. Outcome: CAB membership sustained over project period; Increased satisfaction among CAB members over project period; Increased access to target groups over project period

Identification and implementation of system and environmental strategies: Process: Existing clinical resources identified; trainings available; increased adoption of community-designed STD prevention strategies

Outcome: Community priorities and effective community-designed interventions are identified, implemented and evaluated using partner resources and influence; increased access to/use of community health and resources and support services by target groups; increased access to/use of educational and economic opportunities by target groups; improved availability and accessibility of health education, training, and resources for STD, HIV, and viral hepatitis prevention and control;

increased capacity to raise awareness of health and healthy behaviors; positivity and treatment rates from community events and STD screenings; enhanced capacity to implement public health interventions through purposed and deliberate partnership activities; decreased exposure to social disorder (i.e., presence of trash and lack of cooperation in a community).

Partnerships

Process: Multi-sector partner participation rate; proportion of partners engaged in community and intervention activities; value of leveraged resources; policies adopted or refined;

Outcome: New stable partnerships are formed; extent of environmental change.

Communication:

Process: Level of existing communication;

Outcome: Increased awareness of STD disparities (e.g. adolescents, and YMSM), health issues and community resources; increased access to and use of community health resources and support services by target groups; increased access to and use of educational opportunities by target groups;

implementation of effective health equity and health communication methods.

ii. Applicant Evaluation and Performance Measurement Plan Applicants must provide an evaluation and performance measurement plan that demonstrates how the awardee will fulfill the requirements described in the CDC Evaluation and Performance Measurement and Project Description sections of this FOA. At a minimum, the plan must describe:

How applicant will collect the performance measures, respond to the evaluation questions, and use evaluation findings for continuous program quality improvement.

How key program partners will participate in the evaluation and performance measurement planning processes.

Available data sources, feasibility of collecting appropriate evaluation and performance data, and other relevant data information (e.g., performance measures proposed by the applicant) Plans for updating the Data Management Plan (DMP), if applicable, for accuracy throughout the lifecycle of the project. The DMP should provide a description of the data that will be produced using these FOA funds; access to data; data standards ensuring released data have documentation describing methods of collection, what the data represent, and data limitations; and archival and long-term data preservation plans. For more information about CDC’s policy on the DMP, see https://www.cdc.gov/grants/additionalrequirements/ar-25.html.

Where the applicant chooses to, or is expected to, take on specific evaluation studies, they should be directed to:

Describe the type of evaluations (i.e., process, outcome, or both).

Describe key evaluation questions to be addressed by these evaluations.

Describe other information (e.g., measures, data sources).

Awardees will be required to submit a more detailed Evaluation and Performance Measurement plan, including a DMP, within the first 6 months of award, as described in the Reporting Section of this FOA.

Applicants must provide an overall jurisdiction or community-specific evaluation and performance measurement plan that is consistent with the CDC Evaluation and Performance Measurement Strategy section of the CDC Project Description of this FOA. Data collected must be used for ongoing monitoring of the award to evaluate its effectiveness, and for continuous program improvement.

1.

The plan must:

Identify staff person responsible for conducting and reporting evaluation activities.

Describe how key program partners will be engaged in the evaluation and performance measurement planning processes.

Outline the type of evaluations to be conducted (i.e., process and/or outcome).

List key evaluation questions to be answered.

Identify potentially available data sources and feasibility of collecting appropriate evaluation and performance data.

Discuss how evaluation findings will be used for continuous program and quality improvement.

Describe how evaluation and performance measurement will contribute to development of that evidence base, where program strategies are being employed that lack a strong evidence base of effectiveness.

Provide one example (as an attachment) of a well-designed evaluation assessment tool used during past evaluation efforts.

Describe other information, as determined by the CDC program (e.g., performance measures to be developed by the applicant) that must be included.

Awardees will be required to submit evaluation reports, according to the CDC provided reporting schedule and templates.

https://www.cdc.gov/grants/additionalrequirements/ar-25.html

c. Organizational Capacity of Awardees to Implement the Approach Successful applicants must have the organizational capacity to carry out the strategies and activities described above. Applicants should demonstrate the following:

An existing relationship with the target population in the form of a Community Advisory Board/Council (CAB), and evidence that the CAB reflects and represents the target community. The CAB infrastructure must be suitable for conducting business in an effective and efficient manner.

The ability to leverage partner resources and infrastructure A staffing plan and an organizational chart, including proposed staffing, with roles clearly stated.

(Applicants must name this file “Organizational Charts” and upload it at www.grants.gov.)

Background, experience, and curricula vitae for key staff to indicate ability to carry out the purposes of the program Proposed project management experience and ability to plan, organize, secure and manage resources to successfully accomplish program activities A plan for disseminating project findings Willingness and the capacity to collaborate with other awardees and adhere to common protocols

In addition, applicants must have a financial management system, i.e., an accounting system. At a minimum, this system must:

permit preparation of required reports allow the tracking of funds have effective internal accountability controls/checks and balances maintain source documents have a cash management system to accurately account for cash transactions

d. Work Plan http://www.grants.gov

Applicants are required to provide a work plan consisting of project period goals for the three-year program and Year One objectives for each program strategy. A detailed description of program activities in each area during the first year of the award is also required. The work plan should not exceed 20 pages. Applicants are strongly encouraged to use the activities indicated under the “Program Strategy” section. The work plan must, at a minimum, include:

Project Period Goals (PPG) for each Program Strategy. The proposed PPGs should describe the goals for the 3-year project period.

Annual Objectives (AO) for each PPG. The proposed AOs should describe the short-term objectives for the first year of the project period. Each AO must be specific, measurable, achievable, realistic time-phased goals and consistent with the intent of the program announcement.

A description of specific program activities that will be undertaken during Year One to meet the proposed Annual Objectives must also be provided. The activity descriptions must include (1) timeline for completion; (2) staff responsible for completion of activity, including the level of effort and allocation of time for each proposed activity; and (3) key partners involved in the development, implementation and evaluation of proposed activities including a description of their role.

Note: Annual Objectives should be written in SMART (specific, measurable, achievable, realistic, and timely) format. Quantitative baselines should be provided for each objective that leads to an increase, decrease, or maintenance over time. Activities must be in alignment with the proposed objectives and the chosen program strategies and must include those activities the applicant selects as priority, based on the cited evidence, for the first year of the project.

CDC will provide feedback and technical assistance to awardees to finalize the work plan post-award.

e. CDC Monitoring and Accountability Approach Monitoring activities include routine and ongoing communication between CDC and awardees, site visits, and awardee reporting (including work plans, performance, and financial reporting). Consistent with applicable grants regulations and policies, CDC expects the following to be included in post-award monitoring for grants and cooperative agreements:

Tracking awardee progress in achieving the desired outcomes.

Ensuring the adequacy of awardee systems that underlie and generate data reports.

Creating an environment that fosters integrity in program performance and results.

Monitoring may also include the following activities deemed necessary to monitor the award:

Ensuring that work plans are feasible based on the budget and consistent with the intent of the award.

Ensuring that awardees are performing at a sufficient level to achieve outcomes within stated timeframes.

Working with awardees on adjusting the work plan based on achievement of outcomes, evaluation results and changing budgets.

Monitoring performance measures (both programmatic and financial) to assure satisfactory performance levels.

Monitoring and reporting activities that assist grants management staff (e.g., grants management officers and specialists, and project officers) in the identification, notification, and management of high-risk grantees.

f. CDC Program Support to Awardees (THIS SECTION APPLIES ONLY TO COOPERATIVE

AGREEMENTS)

CDC’s CARS Coordination Team will host a CDC/Grantee meeting at the beginning of the project period to facilitate introduction of all CDC CARS Team members, Office of Grant Services (OGS) Management Specialist, and grantees. Additional CDC Program support shall include, but is not limited to:

Providing technical program expertise and assistance Sharing current project-relevant published articles and research Providing expert evaluation guidance Facilitating CARS grantee collaboration through regular scheduled meetings and webinars Providing a platform for information and resource sharing among group participants as they further explore innovative community engagement approaches to address social determinants of health and ultimately reduce the disparate rates of STDs in identified communities

B. Award Information

1. Funding Instrument Type: Cooperative Agreement CDC's substantial involvement in this program appears in the CDC Program

Support to Awardees Section.

2. Award Mechanism: U22 U22 HIV/STD Prevention Services for Racial and Ethnic Minorities-Cooperative Agreements

3. Fiscal Year: 2017

4. Approximate Total Fiscal Year Funding:

$1,250,000

5. Approximate Project Period Funding:

$3,750,000

This amount is subject to the availability of funds.

Estimated Total Funding: $3,750,000

6. Total Project Period Length:

3 year(s)

7. Expected Number of Awards:

8. Approximate Average Award:

$312,500 Per Budget Period

9. Award Ceiling: $312,500 Per Budget Period

This amount is subject to the availability of funds.

10. Award Floor: $250,000 Per Budget Period

11. Estimated Award Date: 08/28/2017

12. Budget Period Length: 12 month(s)

Throughout the project period, CDC will continue the award based on the availability of funds, the evidence of satisfactory progress by the awardee (as documented in required reports), and the determination that continued funding is in the best interest of the federal government. The total number of years for which federal support has been approved (project period) will be shown in the “Notice of Award.” This information does not constitute a commitment by the federal government to fund the entire period. The total project period comprises the initial competitive segment and any subsequent non-competitive continuation award(s).

13. Direct Assistance Direct Assistance (DA) is not available through this FOA.

Direct Assistance (DA) is not available through this FOA.

C. Eligibility Information

1. Eligible Applicants Eligibility Category: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Additional Eligibility Category:

2. Additional Information on Eligibility

3. Justification for Less than Maximum Competition

4. Cost Sharing or Matching Cost Sharing / Matching Requirement:

No

5. Maintenance of Effort

D. Application and Submission Information

1. Required Registrations An organization must be registered at the three following locations before it can submit an application for funding at www.grants.gov.

a. Data Universal Numbering System:

All applicant organizations must obtain a Data Universal Numbering System (DUNS) number. A DUNS number is a unique nine-digit identification number provided by Dun & Bradstreet (D&B). It will be used as the Universal Identifier when applying for federal awards or cooperative agreements.

The applicant organization may request a DUNS number by telephone at 1-866-705-5711 (toll free) or internet at http:// fedgov.dnb. com/ webform/ displayHomePage.do. The DUNS number will be provided at no charge.

If funds are awarded to an applicant organization that includes sub-awardees, those sub-awardees must provide their DUNS numbers before accepting any funds.

b. System for Award Management (SAM):

The SAM is the primary registrant database for the federal government and the repository into which an entity must submit information required to conduct business as an awardee. All applicant organizations must register with SAM, and will be assigned a SAM number. All information relevant to the SAM number must be current at all times during which the applicant has an application under consideration for funding by CDC.

If an award is made, the SAM information must be maintained until a final financial report is submitted or the final payment is received, whichever is later. The SAM registration process can require 10 or more business days, and registration must be renewed annually. Additional information about registration procedures may be found at www.SAM.gov.

c. Grants.gov:

The first step in submitting an application online is registering your organization at www.grants.gov, the https://www.grants.gov/ http://fedgov.dnb.com/webform/displayHomePage.do https://www.sam.gov/portal/public/SAM/ https://grants.gov/ https://www.grants.gov/ official HHS E-grant Web site. Registration information is located at the “Get Registered” option at www.grants.gov.

All applicant organizations must register at www.grants.gov. The one-time registration process usually takes not more than five days to complete. Applicants should start the registration process as early as possible.

Step System Requirements Duration Follow Up

1 Data Universal Number System

(DUNS)

1. Click on http:// fedgov.dnb.com/ webform

2. Select Begin

DUNS

search/request process

3. Select your country or territory and follow the instructions to obtain your DUNS 9-digit #

4. Request appropriate staff member(s) to obtain DUNS number, verify & update information under DUNS number

1-2 Business Days

To confirm that you have been issued a new DUNS number check online at (http:// fedgov.dnb.com/ webform) or call 1-866-705-5711Image Description:

2 System for Award Management

(SAM)

formerly Central Contractor Registration

(CCR)

1. Retrieve organizations DUNS number

2. Go to www.sam.gov and designate an E-Biz POC (note CCR username will not work in SAM and you will need to have an active SAM account before you can register on grants.gov)

3-5 Business Days but up to 2 weeks and must be renewed once a year

For SAM Customer Service Contact https://fsd.gov/ fsd-gov/ home.do Calls:

866-606-8220Image Description:

https://www.grants.gov/ https://www.grants.gov/ https://www.grants.gov/ http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://www.sam.gov https://fsd.gov/fsd-gov/home.do https://fsd.gov/fsd-gov/home.do

3 Grants.gov 1. Set up an individual account in Grants.gov using organization new DUNS number to become an authorized organization representative

(AOR)

2. Once the account is set up the E-BIZ POC will be notified via email

3. Log into grants.gov using the password the E-BIZ POC received and create new password

4. This authorizes the AOR to submit applications on behalf of the organization

Same day but can take 8 weeks to be fully registered and approved in the system (note, applicants

MUST

obtain a

DUNS

number and SAM account before applying on grants.gov)

Register early! Log into grants.gov and check AOR status until it shows you have been approved

2. Request Application Package Applicants may access the application package at www.grants.gov.

3. Application Package Applicants must download the SF-424, Application for Federal Assistance, package associated with this funding opportunity at www.grants.gov. If Internet access is not available, or if the online forms cannot be accessed, applicants may call the CDC OGS staff at 770-488-2700Image Description: or e-mail OGS ogstims@cdc.gov for assistance. Persons with hearing loss may access CDC telecommunications at TTY 1-888-232-6348Image Description: .

4. Submission Dates and Times If the application is not submitted by the deadline published in the FOA, it will not be processed. Office of Grants Services (OGS) personnel will notify the applicant that their application did not meet the deadline.

The applicant must receive pre-approval to submit a paper application (see Other Submission Requirements section for additional details). If the applicant is authorized to submit a paper application, it must be received by the deadline provided by OGS.

a. Letter of Intent Deadline (must be emailed or postmarked by) Due Date for Letter of Intent: 04/28/2017 https://www.grants.gov https://www.grants.gov mailto:ogstims@cdc.gov

b. Application Deadline Due Date for Applications: 05/30/2017 , 11:59 p.m. U.S. Eastern Standard Time, at www.grants.gov. If Grants.gov is inoperable and cannot receive applications, and circumstances preclude advance notification of an extension, then applications must be submitted by the first business day on which grants.gov operations resume.

Date for Information Conference Call

Informational conference call for potential applicants Thursday, April 20, 2017 1:00-2:30pm EST

Join Skype Meeting

Trouble Joining? Try Skype Web App

Join by phone

(404) 553-8912 (Atlanta Dial-in Conference Region) English (United States)

(855) 348-8390 (Atlanta Dial-in Conference Region) English (United States)

Find a local number

Conference ID: 9285150

Forgot your dial-in PIN? |Help

5. CDC Assurances and Certifications All applicants are required to sign and submit “Assurances and Certifications” documents indicated at http://wwwn.cdc.gov/ grantassurances/ (S(mj444mxct51lnrv1hljjjmaa)) /Homepage.aspx.

Applicants may follow either of the following processes:

Complete the applicable assurances and certifications with each application submission, name the file “Assurances and Certifications” and upload it as a PDF file with at www.grants.gov Complete the applicable assurances and certifications and submit them directly to CDC on an annual basis at http://wwwn.cdc.gov/ grantassurances/ (S(mj444mxct51lnrv1hljjjmaa))/ Homepage.aspx

Assurances and certifications submitted directly to CDC will be kept on file for one year and will apply to all applications submitted to CDC by the applicant within one year of the submission date.

Duplication of Efforts Applicants are responsible for reporting if this application will result in programmatic, budgetary, or commitment overlap with another application or award (i.e. grant, cooperative agreement, or contract) submitted to another funding source in the same fiscal year. Programmatic overlap occurs when (1) substantially the same project is proposed in more than one application or is submitted to two or more funding sources for review and funding consideration or (2) a specific objective and the project design for accomplishing the objective are the same or closely related in two or more applications or awards, regardless of the funding source. Budgetary overlap occurs when duplicate or equivalent budgetary items (e.g., equipment, salaries) are requested in an application but already are provided by another source.

Commitment overlap occurs when an individual’s time commitment exceeds 100 percent, whether or not salary support is requested in the application. Overlap, whether programmatic, budgetary, or commitment of an individual’s effort greater than 100 percent, is not permitted. Any overlap will be resolved by the CDC with the applicant and the PD/PI prior to award.

https://www.grants.gov https://webconf.cdc.gov/nhh9/4M92RZHC https://webconf.cdc.gov/nhh9/4M92RZHC?sl=1 tel:(404)%20553-8912 tel:(855)%20348-8390 https://webaudio.cdc.gov https://webaudio.cdc.gov https://o15.officeredir.microsoft.com/r/rlidLync15?clid=1033&p1=5&p2=2009 http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx

Report Submission: The applicant must upload the report in Grants.gov under “Other Attachment Forms.”

The document should be labeled: "Report on Programmatic, Budgetary, and Commitment Overlap.”

6. Content and Form of Application Submission Applicants are required to include all of the following documents with their application package at www.grants.gov.

7. Letter of Intent The purpose of an LOI is to allow CDC program staff to estimate the number of and plan for the review of submitted applications.

LOI is requested, but not required as part of the application for this FOA.

Applicants are encouraged to submit a LOI with the following information:

Descriptive title of proposed project Name, address, telephone number, and email address of the Principal investigator or Project Director, or both Name, address, telephone number, and email address of the primary contact for writing and submitting this application Number and title of this FOA

LOI must be sent via U.S. express mail, delivery service, fax, or email to:

Email address: NHayes3@cdc.gov

Norman A. Hayes

CDC, NCHHSTP, DSTDP

Address: 1600 Clifton Road, NE, Mailstop E-02

Atlanta, GA 30333

Telephone number: (404) 639-8991

Fax: (404) 639-6430

8. Table of Contents (There is no page limit. The table of contents is not included in the project narrative page limit.): The applicant must provide, as a separate attachment, the “Table of Contents” for the entire submission package.

Provide a detailed table of contents for the entire submission package that includes all of the documents in the application and headings in the "Project Narrative" section. Name the file "Table of Contents" and upload it as a PDF file under "Other Attachment Forms" at www.grants.gov.

9. Project Abstract Summary (Maximum 1 page) A project abstract is included on the mandatory documents list and must be submitted at www.grants.gov.

The project abstract must be a self-contained, brief summary of the proposed project including the purpose and outcomes. This summary must not include any proprietary or confidential information. Applicants must enter the summary in the "Project Abstract Summary" text box at www.grants.gov.

https://www.grants.gov mailto:NHayes3@cdc.gov https://www.grants.gov

10. Project Narrative (Unless specified in the "H. Other Information" section, maximum of 20 pages, single spaced, 12 point font, 1-inch margins, number all pages. This includes the work plan. Content beyond the specified page number will not be reviewed.)

Applicants must submit a Project Narrative with the application forms. Applicants must name this file “Project Narrative” and upload it at www.grants.gov. The Project Narrative must include all of the following headings (including subheadings): Background, Approach, Applicant Evaluation and Performance Measurement Plan, Organizational Capacity of Applicants to Implement the Approach, and Work Plan. The Project Narrative must be succinct, self-explanatory, and in the order outlined in this section. It must address outcomes and activities to be conducted over the entire project period as identified in the CDC Project Description section. Applicants should use the federal plain language guidelines and Clear Communication Index to respond to this Funding Opportunity Announcement. Note that awardees should also use these tools when creating public communication materials supported by this FOA. Failure to follow the guidance and format may negatively impact scoring of the application.

a. Background Applicants must provide a description of relevant background information that includes the context of the problem (See CDC Background).

b. Approach

i. Purpose Applicants must describe in 2-3 sentences specifically how their application will address the public health problem as described in the CDC Background section.

ii. Outcomes Applicants must clearly identify the outcomes they expect to achieve by the end of the project period, as identified in the logic model in the Approach section of the CDC Project Description. Outcomes are the results that the program intends to achieve and usually indicate the intended direction of change (e.g., increase, decrease).

iii. Strategies and Activities Applicants must provide a clear and concise description of the strategies and activities they will use to achieve the project period outcomes. Applicants must select existing evidence-based strategies that meet their needs, or describe in the Applicant Evaluation and Performance Measurement Plan how these strategies will be evaluated over the course of the project period. See the Strategies and Activities section of the CDC Project Description.

1. Collaborations Applicants must describe how they will collaborate with programs and organizations either internal or external to CDC. Applicants must address the Collaboration requirements as described in the CDC Project Description.

2. Target Populations and Health Disparities Applicants must describe the specific target population(s) in their jurisdiction and explain how such a target will achieve the goals of the award and/or alleviate health disparities. The applicants must also address how they will include specific populations that can benefit from the program that is described in the Approach section.